Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.64305757 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64283779 |
3 | neutrophil activation involved in immune response (GO:0002283) | 4.59961541 |
4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.54513676 |
5 | ATP synthesis coupled proton transport (GO:0015986) | 4.54513676 |
6 | presynaptic membrane assembly (GO:0097105) | 4.51914910 |
7 | DNA double-strand break processing (GO:0000729) | 4.48602925 |
8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.29057721 |
9 | platelet dense granule organization (GO:0060155) | 4.25193850 |
10 | intraciliary transport (GO:0042073) | 4.17616572 |
11 | phagosome maturation (GO:0090382) | 4.17202222 |
12 | presynaptic membrane organization (GO:0097090) | 4.04646828 |
13 | respiratory electron transport chain (GO:0022904) | 3.94848197 |
14 | cytochrome complex assembly (GO:0017004) | 3.90716191 |
15 | electron transport chain (GO:0022900) | 3.84210321 |
16 | protein neddylation (GO:0045116) | 3.81654810 |
17 | protein complex biogenesis (GO:0070271) | 3.81098156 |
18 | protein localization to cilium (GO:0061512) | 3.78101695 |
19 | eosinophil chemotaxis (GO:0048245) | 3.76621822 |
20 | superoxide anion generation (GO:0042554) | 3.70096581 |
21 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.69921159 |
22 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.69921159 |
23 | signal peptide processing (GO:0006465) | 3.59209490 |
24 | transferrin transport (GO:0033572) | 3.56287909 |
25 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.54699293 |
26 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.54395835 |
27 | NADH dehydrogenase complex assembly (GO:0010257) | 3.54395835 |
28 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.54395835 |
29 | protein deneddylation (GO:0000338) | 3.49060671 |
30 | cullin deneddylation (GO:0010388) | 3.47147248 |
31 | neuron cell-cell adhesion (GO:0007158) | 3.46303308 |
32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.45765243 |
33 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.42474838 |
34 | respiratory burst (GO:0045730) | 3.41359280 |
35 | chaperone-mediated protein transport (GO:0072321) | 3.39932171 |
36 | eosinophil migration (GO:0072677) | 3.39913173 |
37 | proteasome assembly (GO:0043248) | 3.39683173 |
38 | neuron fate determination (GO:0048664) | 3.37867139 |
39 | postsynaptic membrane organization (GO:0001941) | 3.36169973 |
40 | respiratory chain complex IV assembly (GO:0008535) | 3.34346890 |
41 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.33473805 |
42 | neural tube formation (GO:0001841) | 3.32101392 |
43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.30746928 |
44 | response to peptidoglycan (GO:0032494) | 3.28093468 |
45 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.27491641 |
46 | ferric iron transport (GO:0015682) | 3.26262498 |
47 | trivalent inorganic cation transport (GO:0072512) | 3.26262498 |
48 | cilium morphogenesis (GO:0060271) | 3.25949071 |
49 | epithelial cilium movement (GO:0003351) | 3.25600393 |
50 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.20938749 |
51 | behavioral response to nicotine (GO:0035095) | 3.20327048 |
52 | regulation of cilium movement (GO:0003352) | 3.18369451 |
53 | protein-cofactor linkage (GO:0018065) | 3.13844609 |
54 | endosome to pigment granule transport (GO:0043485) | 3.12005708 |
55 | endosome to melanosome transport (GO:0035646) | 3.12005708 |
56 | nonmotile primary cilium assembly (GO:0035058) | 3.09253185 |
57 | cellular response to zinc ion (GO:0071294) | 3.07705615 |
58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02653959 |
59 | heart contraction (GO:0060047) | 3.00732314 |
60 | heart process (GO:0003015) | 3.00732314 |
61 | cellular response to interferon-beta (GO:0035458) | 2.99557483 |
62 | nucleobase catabolic process (GO:0046113) | 2.97904474 |
63 | reactive oxygen species biosynthetic process (GO:1903409) | 2.96596800 |
64 | negative regulation of mast cell activation (GO:0033004) | 2.96259551 |
65 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.96074980 |
66 | axoneme assembly (GO:0035082) | 2.93149205 |
67 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.92692873 |
68 | C4-dicarboxylate transport (GO:0015740) | 2.90779937 |
69 | limb bud formation (GO:0060174) | 2.89782200 |
70 | glycosphingolipid biosynthetic process (GO:0006688) | 2.88440266 |
71 | immunoglobulin mediated immune response (GO:0016064) | 2.87909511 |
72 | gamma-aminobutyric acid transport (GO:0015812) | 2.87275814 |
73 | sequestering of actin monomers (GO:0042989) | 2.85068697 |
74 | neutrophil activation (GO:0042119) | 2.82885327 |
75 | hydrogen ion transmembrane transport (GO:1902600) | 2.82500894 |
76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80934434 |
77 | modulation by symbiont of host defense response (GO:0052031) | 2.80934434 |
78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80934434 |
79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80934434 |
80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80934434 |
81 | modulation by symbiont of host immune response (GO:0052553) | 2.80934434 |
82 | cilium organization (GO:0044782) | 2.80604430 |
83 | retinal ganglion cell axon guidance (GO:0031290) | 2.80333135 |
84 | granulocyte activation (GO:0036230) | 2.80231657 |
85 | anterograde synaptic vesicle transport (GO:0048490) | 2.78146933 |
86 | intracellular pH reduction (GO:0051452) | 2.75060130 |
87 | cilium assembly (GO:0042384) | 2.75003393 |
88 | oxidative phosphorylation (GO:0006119) | 2.74191511 |
89 | ribonucleoprotein complex disassembly (GO:0032988) | 2.73096913 |
90 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.72475005 |
91 | response to interferon-beta (GO:0035456) | 2.72169388 |
92 | regulation of heat generation (GO:0031650) | 2.70369103 |
93 | organelle disassembly (GO:1903008) | 2.68695444 |
94 | DNA integration (GO:0015074) | 2.67874135 |
95 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67785708 |
96 | inositol phosphate catabolic process (GO:0071545) | 2.67228164 |
97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.66938906 |
98 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.65787522 |
99 | regulation of glucokinase activity (GO:0033131) | 2.65652559 |
100 | regulation of hexokinase activity (GO:1903299) | 2.65652559 |
101 | photoreceptor cell maintenance (GO:0045494) | 2.65621857 |
102 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.64991361 |
103 | regulation of feeding behavior (GO:0060259) | 2.64005408 |
104 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.62398576 |
105 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.62246174 |
106 | proton transport (GO:0015992) | 2.61681612 |
107 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.61657974 |
108 | pH reduction (GO:0045851) | 2.58902077 |
109 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.57670616 |
110 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.57670616 |
111 | 7-methylguanosine mRNA capping (GO:0006370) | 2.57528311 |
112 | metallo-sulfur cluster assembly (GO:0031163) | 2.56870596 |
113 | iron-sulfur cluster assembly (GO:0016226) | 2.56870596 |
114 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.56819211 |
115 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.56819211 |
116 | cilium movement (GO:0003341) | 2.55829044 |
117 | hydrogen transport (GO:0006818) | 2.55655837 |
118 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54639586 |
119 | behavioral response to ethanol (GO:0048149) | 2.53790401 |
120 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.53168054 |
121 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.53168054 |
122 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.53168054 |
123 | dopamine transport (GO:0015872) | 2.52405003 |
124 | 7-methylguanosine RNA capping (GO:0009452) | 2.51490610 |
125 | RNA capping (GO:0036260) | 2.51490610 |
126 | myeloid dendritic cell activation (GO:0001773) | 2.51321764 |
127 | regulation of meiosis I (GO:0060631) | 2.50904080 |
128 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.49664181 |
129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49485755 |
130 | regulation of fever generation (GO:0031620) | 2.48910707 |
131 | reflex (GO:0060004) | 2.48869700 |
132 | protein prenylation (GO:0018342) | 2.48844629 |
133 | prenylation (GO:0097354) | 2.48844629 |
134 | regulation of mast cell activation (GO:0033003) | 2.47707209 |
135 | aerobic respiration (GO:0009060) | 2.47442142 |
136 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.45499405 |
137 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.45350571 |
138 | positive regulation of interferon-alpha production (GO:0032727) | 2.44961854 |
139 | fatty acid elongation (GO:0030497) | 2.44582042 |
140 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.44558520 |
141 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.44558520 |
142 | peptidyl-histidine modification (GO:0018202) | 2.44347682 |
143 | myeloid dendritic cell differentiation (GO:0043011) | 2.44209302 |
144 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43112066 |
145 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.40967161 |
146 | retinal rod cell development (GO:0046548) | 2.40864270 |
147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.40211322 |
148 | cellular ketone body metabolic process (GO:0046950) | 2.39604643 |
149 | DNA demethylation (GO:0080111) | 2.39333045 |
150 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.39222043 |
151 | positive regulation of mast cell degranulation (GO:0043306) | 2.39222043 |
152 | regulation of mononuclear cell migration (GO:0071675) | 2.38870195 |
153 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.38686124 |
154 | neurotransmitter uptake (GO:0001504) | 2.38542636 |
155 | melanosome transport (GO:0032402) | 2.37738395 |
156 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.37095731 |
157 | DNA damage response, detection of DNA damage (GO:0042769) | 2.37053348 |
158 | proline transport (GO:0015824) | 2.36552609 |
159 | axonal fasciculation (GO:0007413) | 2.35824441 |
160 | positive regulation of mitochondrial fission (GO:0090141) | 2.35816104 |
161 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35721625 |
162 | regulation of respiratory system process (GO:0044065) | 2.35273540 |
163 | regulation of mast cell degranulation (GO:0043304) | 2.35134494 |
164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34898280 |
165 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.34346969 |
166 | positive regulation of lymphocyte migration (GO:2000403) | 2.34225037 |
167 | GPI anchor metabolic process (GO:0006505) | 2.34178823 |
168 | establishment of melanosome localization (GO:0032401) | 2.33933095 |
169 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.33884893 |
170 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.33884893 |
171 | kidney morphogenesis (GO:0060993) | 2.33868925 |
172 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.33137596 |
173 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.33099076 |
174 | peptidyl-cysteine modification (GO:0018198) | 2.32777719 |
175 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.32615857 |
176 | inner ear receptor stereocilium organization (GO:0060122) | 2.31944783 |
177 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.31444852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.16845197 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41131041 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.07665316 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.80010773 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59388416 |
6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.21850345 |
7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.11082944 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.00866640 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76019695 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.71686377 |
11 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.64610429 |
12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.51293285 |
13 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.44761786 |
14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.38957167 |
15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.30415173 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.29227019 |
17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.25303866 |
18 | EWS_26573619_Chip-Seq_HEK293_Human | 2.23162115 |
19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.23071554 |
20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.20501249 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17176916 |
22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15281415 |
23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08272020 |
24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.07033911 |
25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06451063 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06352822 |
27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03023151 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00021197 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97495687 |
30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96910641 |
31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.95246549 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95207911 |
33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93790610 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89031668 |
35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88697752 |
36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86434035 |
37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.85755889 |
38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83121458 |
39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76397733 |
40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76143019 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.73950437 |
42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73438282 |
43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70920883 |
44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68356552 |
45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67456971 |
46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.64034318 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62029872 |
48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62005013 |
49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61631710 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.61198960 |
51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60540394 |
52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59913229 |
53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59459299 |
54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58292778 |
55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58258634 |
56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.56880790 |
57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56452956 |
58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53267397 |
59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50510422 |
60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50025337 |
61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48869573 |
62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48151407 |
63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47960930 |
64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.47337838 |
65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44619770 |
66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44479905 |
67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44354015 |
68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43942226 |
69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43900010 |
70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.43558445 |
71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.43558445 |
72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42797162 |
73 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42718663 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41474490 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41474490 |
76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41157717 |
77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40665981 |
78 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39392100 |
79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37929616 |
80 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.37072301 |
81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36306956 |
82 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35466543 |
83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34292598 |
84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32536782 |
85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31202839 |
86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31049706 |
87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31014197 |
88 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.30700498 |
89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29880554 |
90 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29835919 |
91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29393679 |
92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29109543 |
93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28816807 |
94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28341720 |
95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28341720 |
96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28080199 |
97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.27779826 |
98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27465542 |
99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27411324 |
100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25960039 |
101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25311244 |
102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24859444 |
103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24042721 |
104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23525913 |
105 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23476589 |
106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20530915 |
107 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.18473431 |
108 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18304939 |
109 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18016430 |
110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17531111 |
111 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17473567 |
112 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17328637 |
113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17263235 |
114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16986443 |
115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16986443 |
116 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16826594 |
117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16498813 |
118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15547266 |
119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14088352 |
120 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13879922 |
121 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13624827 |
122 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13246346 |
123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13144956 |
124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12995814 |
125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12752466 |
126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12381287 |
127 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12225439 |
128 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11625687 |
129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10272029 |
130 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09868026 |
131 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09805433 |
132 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08648854 |
133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08618002 |
134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07934591 |
135 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06892121 |
136 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.06006721 |
137 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05509777 |
138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05405422 |
139 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04944968 |
140 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04237480 |
141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04018159 |
142 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04015804 |
143 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03844554 |
144 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03736017 |
145 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03641301 |
146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02812009 |
147 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02690235 |
148 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01809794 |
149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01520353 |
150 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01290591 |
151 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99831776 |
152 | P300_19829295_ChIP-Seq_ESCs_Human | 0.99709850 |
153 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99199597 |
154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99159372 |
155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98848390 |
156 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96794285 |
157 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96567787 |
158 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94677454 |
159 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94271337 |
160 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93797026 |
161 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93693431 |
162 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89551147 |
163 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89238362 |
164 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89146478 |
165 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88976704 |
166 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87958929 |
167 | JUN_21703547_ChIP-Seq_K562_Human | 0.86593839 |
168 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.85318868 |
169 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83714771 |
170 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83475411 |
171 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82814925 |
172 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82726299 |
173 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80729237 |
174 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80015648 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002148_abnormal_hypersensitivity_rea | 3.36933069 |
2 | MP0001835_abnormal_antigen_presentation | 3.34135005 |
3 | MP0003724_increased_susceptibility_to | 2.98876792 |
4 | MP0009785_altered_susceptibility_to | 2.97941202 |
5 | MP0002102_abnormal_ear_morphology | 2.79599580 |
6 | MP0003646_muscle_fatigue | 2.74487184 |
7 | MP0001984_abnormal_olfaction | 2.67161937 |
8 | MP0002822_catalepsy | 2.62017078 |
9 | MP0003436_decreased_susceptibility_to | 2.60460851 |
10 | MP0010386_abnormal_urinary_bladder | 2.38111331 |
11 | MP0005000_abnormal_immune_tolerance | 2.36869133 |
12 | MP0005671_abnormal_response_to | 2.32974039 |
13 | MP0006072_abnormal_retinal_apoptosis | 2.31420083 |
14 | MP0006082_CNS_inflammation | 2.27218759 |
15 | MP0002419_abnormal_innate_immunity | 2.25438406 |
16 | MP0004510_myositis | 2.22877482 |
17 | MP0002837_dystrophic_cardiac_calcinosis | 2.15888308 |
18 | MP0008877_abnormal_DNA_methylation | 2.13470698 |
19 | MP0000569_abnormal_digit_pigmentation | 2.10411208 |
20 | MP0005025_abnormal_response_to | 2.01856086 |
21 | MP0005084_abnormal_gallbladder_morpholo | 1.92868683 |
22 | MP0003787_abnormal_imprinting | 1.91569571 |
23 | MP0005253_abnormal_eye_physiology | 1.89838575 |
24 | MP0009745_abnormal_behavioral_response | 1.86788060 |
25 | MP0004885_abnormal_endolymph | 1.84527821 |
26 | MP0005058_abnormal_lysosome_morphology | 1.83816145 |
27 | MP0004142_abnormal_muscle_tone | 1.82573707 |
28 | MP0000343_altered_response_to | 1.81128040 |
29 | MP0003122_maternal_imprinting | 1.81061582 |
30 | MP0001986_abnormal_taste_sensitivity | 1.80417140 |
31 | MP0002452_abnormal_antigen_presenting | 1.79895972 |
32 | MP0004270_analgesia | 1.75501821 |
33 | MP0002272_abnormal_nervous_system | 1.75217856 |
34 | MP0005551_abnormal_eye_electrophysiolog | 1.74650588 |
35 | MP0002638_abnormal_pupillary_reflex | 1.69925917 |
36 | MP0002332_abnormal_exercise_endurance | 1.67060671 |
37 | MP0002723_abnormal_immune_serum | 1.66630596 |
38 | MP0000685_abnormal_immune_system | 1.65694340 |
39 | MP0005387_immune_system_phenotype | 1.64124458 |
40 | MP0001790_abnormal_immune_system | 1.64124458 |
41 | MP0000372_irregular_coat_pigmentation | 1.62863343 |
42 | MP0005171_absent_coat_pigmentation | 1.62244863 |
43 | MP0002876_abnormal_thyroid_physiology | 1.61965391 |
44 | MP0002163_abnormal_gland_morphology | 1.61941746 |
45 | MP0008260_abnormal_autophagy | 1.59388204 |
46 | MP0005423_abnormal_somatic_nervous | 1.58754932 |
47 | MP0008789_abnormal_olfactory_epithelium | 1.58725190 |
48 | MP0001486_abnormal_startle_reflex | 1.58459651 |
49 | MP0009333_abnormal_splenocyte_physiolog | 1.57196609 |
50 | MP0003121_genomic_imprinting | 1.56656879 |
51 | MP0003880_abnormal_central_pattern | 1.56490809 |
52 | MP0001819_abnormal_immune_cell | 1.56314805 |
53 | MP0005367_renal/urinary_system_phenotyp | 1.54031149 |
54 | MP0000516_abnormal_urinary_system | 1.54031149 |
55 | MP0002420_abnormal_adaptive_immunity | 1.53967255 |
56 | MP0003011_delayed_dark_adaptation | 1.53814075 |
57 | MP0001533_abnormal_skeleton_physiology | 1.51782624 |
58 | MP0001800_abnormal_humoral_immune | 1.49587292 |
59 | MP0004215_abnormal_myocardial_fiber | 1.47766244 |
60 | MP0004147_increased_porphyrin_level | 1.46604673 |
61 | MP0002090_abnormal_vision | 1.43804886 |
62 | MP0003136_yellow_coat_color | 1.43242712 |
63 | MP0000778_abnormal_nervous_system | 1.43014070 |
64 | MP0006036_abnormal_mitochondrial_physio | 1.42732207 |
65 | MP0002928_abnormal_bile_duct | 1.42015649 |
66 | MP0003186_abnormal_redox_activity | 1.40005615 |
67 | MP0001905_abnormal_dopamine_level | 1.39358501 |
68 | MP0002734_abnormal_mechanical_nocicepti | 1.38905638 |
69 | MP0002572_abnormal_emotion/affect_behav | 1.36491860 |
70 | MP0002938_white_spotting | 1.36104436 |
71 | MP0000631_abnormal_neuroendocrine_gland | 1.34400575 |
72 | MP0000015_abnormal_ear_pigmentation | 1.33970302 |
73 | MP0005379_endocrine/exocrine_gland_phen | 1.33765356 |
74 | MP0003828_pulmonary_edema | 1.33509391 |
75 | MP0002405_respiratory_system_inflammati | 1.32657349 |
76 | MP0002064_seizures | 1.32586825 |
77 | MP0000749_muscle_degeneration | 1.32174053 |
78 | MP0005310_abnormal_salivary_gland | 1.29764953 |
79 | MP0002751_abnormal_autonomic_nervous | 1.29281836 |
80 | MP0002909_abnormal_adrenal_gland | 1.28973592 |
81 | MP0005394_taste/olfaction_phenotype | 1.28909704 |
82 | MP0005499_abnormal_olfactory_system | 1.28909704 |
83 | MP0003635_abnormal_synaptic_transmissio | 1.28667226 |
84 | MP0001188_hyperpigmentation | 1.28069033 |
85 | MP0005645_abnormal_hypothalamus_physiol | 1.27397226 |
86 | MP0004133_heterotaxia | 1.26257948 |
87 | MP0001853_heart_inflammation | 1.26253756 |
88 | MP0006292_abnormal_olfactory_placode | 1.25515352 |
89 | MP0004484_altered_response_of | 1.24599358 |
90 | MP0009046_muscle_twitch | 1.23283147 |
91 | MP0004043_abnormal_pH_regulation | 1.21770085 |
92 | MP0001970_abnormal_pain_threshold | 1.21483694 |
93 | MP0006035_abnormal_mitochondrial_morpho | 1.21309498 |
94 | MP0009764_decreased_sensitivity_to | 1.21081041 |
95 | MP0002736_abnormal_nociception_after | 1.20933640 |
96 | MP0004782_abnormal_surfactant_physiolog | 1.20814767 |
97 | MP0005464_abnormal_platelet_physiology | 1.20108295 |
98 | MP0002557_abnormal_social/conspecific_i | 1.19527220 |
99 | MP0000427_abnormal_hair_cycle | 1.19051359 |
100 | MP0005248_abnormal_Harderian_gland | 1.17752979 |
101 | MP0002972_abnormal_cardiac_muscle | 1.17278619 |
102 | MP0003195_calcinosis | 1.15247923 |
103 | MP0001529_abnormal_vocalization | 1.14764145 |
104 | MP0001845_abnormal_inflammatory_respons | 1.14518015 |
105 | MP0004924_abnormal_behavior | 1.13205289 |
106 | MP0005386_behavior/neurological_phenoty | 1.13205289 |
107 | MP0003718_maternal_effect | 1.12561925 |
108 | MP0003890_abnormal_embryonic-extraembry | 1.12557393 |
109 | MP0005174_abnormal_tail_pigmentation | 1.11614550 |
110 | MP0001542_abnormal_bone_strength | 1.11034227 |
111 | MP0001485_abnormal_pinna_reflex | 1.10973958 |
112 | MP0002067_abnormal_sensory_capabilities | 1.06311461 |
113 | MP0006054_spinal_hemorrhage | 1.06259709 |
114 | MP0002063_abnormal_learning/memory/cond | 1.05967137 |
115 | MP0002277_abnormal_respiratory_mucosa | 1.05230245 |
116 | MP0002735_abnormal_chemical_nociception | 1.04121272 |
117 | MP0008058_abnormal_DNA_repair | 1.04097581 |
118 | MP0003303_peritoneal_inflammation | 1.04070647 |
119 | MP0002733_abnormal_thermal_nociception | 1.03305935 |
120 | MP0009697_abnormal_copulation | 1.02518396 |
121 | MP0003252_abnormal_bile_duct | 1.01932164 |
122 | MP0003137_abnormal_impulse_conducting | 1.01105031 |
123 | MP0004036_abnormal_muscle_relaxation | 1.00238565 |
124 | MP0000681_abnormal_thyroid_gland | 1.00090344 |
125 | MP0001968_abnormal_touch/_nociception | 1.00035780 |
126 | MP0004084_abnormal_cardiac_muscle | 0.99339347 |
127 | MP0008469_abnormal_protein_level | 0.99125221 |
128 | MP0002998_abnormal_bone_remodeling | 0.98269118 |
129 | MP0004859_abnormal_synaptic_plasticity | 0.97766946 |
130 | MP0002282_abnormal_trachea_morphology | 0.97320139 |
131 | MP0008004_abnormal_stomach_pH | 0.96626077 |
132 | MP0008995_early_reproductive_senescence | 0.96406903 |
133 | MP0005390_skeleton_phenotype | 0.95916017 |
134 | MP0000858_altered_metastatic_potential | 0.95751114 |
135 | MP0003448_altered_tumor_morphology | 0.95454616 |
136 | MP0000716_abnormal_immune_system | 0.94574364 |
137 | MP0002398_abnormal_bone_marrow | 0.94039595 |
138 | MP0002693_abnormal_pancreas_physiology | 0.93337676 |
139 | MP0000049_abnormal_middle_ear | 0.92689670 |
140 | MP0000647_abnormal_sebaceous_gland | 0.92565950 |
141 | MP0002877_abnormal_melanocyte_morpholog | 0.92109612 |
142 | MP0002653_abnormal_ependyma_morphology | 0.92062063 |
143 | MP0008872_abnormal_physiological_respon | 0.91774194 |
144 | MP0003656_abnormal_erythrocyte_physiolo | 0.91474797 |
145 | MP0002254_reproductive_system_inflammat | 0.91457543 |
146 | MP0000026_abnormal_inner_ear | 0.90785758 |
147 | MP0002234_abnormal_pharynx_morphology | 0.89683839 |
148 | MP0002184_abnormal_innervation | 0.88393329 |
149 | MP0001501_abnormal_sleep_pattern | 0.88083415 |
150 | MP0005164_abnormal_response_to | 0.87226283 |
151 | MP0010678_abnormal_skin_adnexa | 0.86684428 |
152 | MP0005075_abnormal_melanosome_morpholog | 0.86478884 |
153 | MP0001544_abnormal_cardiovascular_syste | 0.85398113 |
154 | MP0005385_cardiovascular_system_phenoty | 0.85398113 |
155 | MP0002233_abnormal_nose_morphology | 0.84352919 |
156 | MP0001879_abnormal_lymphatic_vessel | 0.83760578 |
157 | MP0005195_abnormal_posterior_eye | 0.83022270 |
158 | MP0001764_abnormal_homeostasis | 0.82958287 |
159 | MP0009379_abnormal_foot_pigmentation | 0.82733580 |
160 | MP0000013_abnormal_adipose_tissue | 0.82601175 |
161 | MP0002752_abnormal_somatic_nervous | 0.80452710 |
162 | MP0001963_abnormal_hearing_physiology | 0.80260240 |
163 | MP0002933_joint_inflammation | 0.80105979 |
164 | MP0001727_abnormal_embryo_implantation | 0.79739419 |
165 | MP0005646_abnormal_pituitary_gland | 0.79261004 |
166 | MP0002429_abnormal_blood_cell | 0.78157785 |
167 | MP0003941_abnormal_skin_development | 0.76821585 |
168 | MP0005503_abnormal_tendon_morphology | 0.76532922 |
169 | MP0008775_abnormal_heart_ventricle | 0.75492263 |
170 | MP0000751_myopathy | 0.74917181 |
171 | MP0000689_abnormal_spleen_morphology | 0.74040339 |
172 | MP0003183_abnormal_peptide_metabolism | 0.72949646 |
173 | MP0006276_abnormal_autonomic_nervous | 0.72216812 |
174 | MP0002095_abnormal_skin_pigmentation | 0.70677716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.34650854 |
2 | Recurrent abscess formation (HP:0002722) | 5.05475857 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.01613679 |
4 | Mitochondrial inheritance (HP:0001427) | 4.92556889 |
5 | Hepatocellular necrosis (HP:0001404) | 4.46681435 |
6 | Progressive macrocephaly (HP:0004481) | 4.39355542 |
7 | Increased CSF lactate (HP:0002490) | 4.28110089 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.25073941 |
9 | Eczematoid dermatitis (HP:0000976) | 3.96028859 |
10 | Hepatic necrosis (HP:0002605) | 3.85945973 |
11 | Acute encephalopathy (HP:0006846) | 3.81101720 |
12 | Pancreatic cysts (HP:0001737) | 3.54919881 |
13 | Vacuolated lymphocytes (HP:0001922) | 3.36819967 |
14 | Molar tooth sign on MRI (HP:0002419) | 3.29872638 |
15 | Abnormality of midbrain morphology (HP:0002418) | 3.29872638 |
16 | Esophageal neoplasm (HP:0100751) | 3.25701784 |
17 | Neoplasm of head and neck (HP:0012288) | 3.25701784 |
18 | Abnormality of macrophages (HP:0004311) | 3.22794703 |
19 | Nephronophthisis (HP:0000090) | 3.22316126 |
20 | Abnormality of glycolysis (HP:0004366) | 3.21756039 |
21 | Increased serum pyruvate (HP:0003542) | 3.21756039 |
22 | Pancreatic fibrosis (HP:0100732) | 3.19530516 |
23 | Hypothermia (HP:0002045) | 3.16330286 |
24 | Exercise intolerance (HP:0003546) | 3.14877106 |
25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07645011 |
26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07645011 |
27 | Hemiparesis (HP:0001269) | 3.06485465 |
28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04214005 |
29 | Gait imbalance (HP:0002141) | 3.03515251 |
30 | Respiratory failure (HP:0002878) | 2.98292230 |
31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.96375298 |
32 | Congenital primary aphakia (HP:0007707) | 2.95211586 |
33 | Increased hepatocellular lipid droplets (HP:0006565) | 2.92966031 |
34 | Mediastinal lymphadenopathy (HP:0100721) | 2.87298142 |
35 | Methylmalonic acidemia (HP:0002912) | 2.86783688 |
36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.81763088 |
37 | Optic disc pallor (HP:0000543) | 2.77816964 |
38 | Lactic acidosis (HP:0003128) | 2.74435580 |
39 | Abnormality of the renal medulla (HP:0100957) | 2.73134496 |
40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69535853 |
41 | Abnormality of alanine metabolism (HP:0010916) | 2.69535853 |
42 | Hyperalaninemia (HP:0003348) | 2.69535853 |
43 | Vertebral compression fractures (HP:0002953) | 2.68189578 |
44 | Exertional dyspnea (HP:0002875) | 2.68022553 |
45 | Obstructive lung disease (HP:0006536) | 2.63831038 |
46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63831038 |
47 | Genital tract atresia (HP:0001827) | 2.63739856 |
48 | Neuroendocrine neoplasm (HP:0100634) | 2.63658944 |
49 | Intestinal atresia (HP:0011100) | 2.63634089 |
50 | Increased serum lactate (HP:0002151) | 2.62036372 |
51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58447143 |
52 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.56739941 |
53 | Abolished electroretinogram (ERG) (HP:0000550) | 2.55674201 |
54 | Hyperventilation (HP:0002883) | 2.53324703 |
55 | Vaginal atresia (HP:0000148) | 2.49387368 |
56 | Myositis (HP:0100614) | 2.47472165 |
57 | Renal Fanconi syndrome (HP:0001994) | 2.46467873 |
58 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43004933 |
59 | Increased cerebral lipofuscin (HP:0011813) | 2.41329561 |
60 | Recurrent skin infections (HP:0001581) | 2.39290459 |
61 | Retrobulbar optic neuritis (HP:0100654) | 2.39282413 |
62 | Optic neuritis (HP:0100653) | 2.39282413 |
63 | Abnormality of the renal cortex (HP:0011035) | 2.35434104 |
64 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27982483 |
65 | Type I transferrin isoform profile (HP:0003642) | 2.26552765 |
66 | Type II lissencephaly (HP:0007260) | 2.24235255 |
67 | Respiratory difficulties (HP:0002880) | 2.23962276 |
68 | Pheochromocytoma (HP:0002666) | 2.23613535 |
69 | Methylmalonic aciduria (HP:0012120) | 2.23461138 |
70 | Chronic hepatic failure (HP:0100626) | 2.21738774 |
71 | Orchitis (HP:0100796) | 2.16233395 |
72 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13036267 |
73 | Poor head control (HP:0002421) | 2.09549501 |
74 | Tinnitus (HP:0000360) | 2.09455592 |
75 | Polyphagia (HP:0002591) | 2.09402939 |
76 | Microvesicular hepatic steatosis (HP:0001414) | 2.09132326 |
77 | Abnormality of the labia minora (HP:0012880) | 2.09110100 |
78 | Cerebral edema (HP:0002181) | 2.04612899 |
79 | Abnormal hair whorl (HP:0010721) | 2.04513373 |
80 | Split foot (HP:0001839) | 2.03798554 |
81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02995996 |
82 | Stomatitis (HP:0010280) | 2.01596436 |
83 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01143688 |
84 | Limb dystonia (HP:0002451) | 2.00895022 |
85 | Gingivitis (HP:0000230) | 1.99354625 |
86 | Petechiae (HP:0000967) | 1.98777021 |
87 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.98645831 |
88 | Agnosia (HP:0010524) | 1.98449653 |
89 | Oligodactyly (hands) (HP:0001180) | 1.97705076 |
90 | Hypoglycemic coma (HP:0001325) | 1.97695430 |
91 | Irregular epiphyses (HP:0010582) | 1.96810161 |
92 | Postaxial hand polydactyly (HP:0001162) | 1.96351863 |
93 | Hypokinesia (HP:0002375) | 1.95236601 |
94 | Tubular atrophy (HP:0000092) | 1.94903399 |
95 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94081725 |
96 | Polydipsia (HP:0001959) | 1.93815263 |
97 | Abnormal drinking behavior (HP:0030082) | 1.93815263 |
98 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91795279 |
99 | Hyperglycinemia (HP:0002154) | 1.91498598 |
100 | Metaphyseal dysplasia (HP:0100255) | 1.90418042 |
101 | Drooling (HP:0002307) | 1.90321403 |
102 | Abnormality of urine glucose concentration (HP:0011016) | 1.88708291 |
103 | Glycosuria (HP:0003076) | 1.88708291 |
104 | Autoimmune thrombocytopenia (HP:0001973) | 1.88484394 |
105 | Increased muscle lipid content (HP:0009058) | 1.86452574 |
106 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86347853 |
107 | Dialeptic seizures (HP:0011146) | 1.85809292 |
108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85582226 |
109 | Large for gestational age (HP:0001520) | 1.85556145 |
110 | Focal motor seizures (HP:0011153) | 1.84617516 |
111 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84528718 |
112 | Absent speech (HP:0001344) | 1.84382768 |
113 | Basal ganglia calcification (HP:0002135) | 1.83853999 |
114 | Renal cortical cysts (HP:0000803) | 1.83591708 |
115 | Atonic seizures (HP:0010819) | 1.83273944 |
116 | Febrile seizures (HP:0002373) | 1.83233878 |
117 | Poor coordination (HP:0002370) | 1.83052583 |
118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.82935522 |
119 | Abnormal biliary tract physiology (HP:0012439) | 1.82933115 |
120 | Bile duct proliferation (HP:0001408) | 1.82933115 |
121 | Recurrent fungal infections (HP:0002841) | 1.81879636 |
122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81733537 |
123 | Prostate neoplasm (HP:0100787) | 1.81648331 |
124 | Broad-based gait (HP:0002136) | 1.81038847 |
125 | Ketoacidosis (HP:0001993) | 1.80072594 |
126 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.78496305 |
127 | Supernumerary spleens (HP:0009799) | 1.78332684 |
128 | True hermaphroditism (HP:0010459) | 1.77877685 |
129 | Recurrent pneumonia (HP:0006532) | 1.77631715 |
130 | Lissencephaly (HP:0001339) | 1.77609121 |
131 | Hypomagnesemia (HP:0002917) | 1.77304651 |
132 | Oculomotor apraxia (HP:0000657) | 1.77095648 |
133 | Short tibia (HP:0005736) | 1.76928334 |
134 | Gaze-evoked nystagmus (HP:0000640) | 1.76879759 |
135 | Agitation (HP:0000713) | 1.76458254 |
136 | Gliosis (HP:0002171) | 1.76054962 |
137 | Mutism (HP:0002300) | 1.76028492 |
138 | Disproportionate short-trunk short stature (HP:0003521) | 1.75416777 |
139 | Optic nerve hypoplasia (HP:0000609) | 1.74904344 |
140 | Hypoplasia of the fovea (HP:0007750) | 1.74700433 |
141 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.74700433 |
142 | Male pseudohermaphroditism (HP:0000037) | 1.74661129 |
143 | Increased IgM level (HP:0003496) | 1.74294066 |
144 | Anencephaly (HP:0002323) | 1.74224091 |
145 | Narrow forehead (HP:0000341) | 1.72318276 |
146 | Abnormality of the anterior horn cell (HP:0006802) | 1.72310549 |
147 | Degeneration of anterior horn cells (HP:0002398) | 1.72310549 |
148 | Sclerocornea (HP:0000647) | 1.72193909 |
149 | Leukodystrophy (HP:0002415) | 1.72004808 |
150 | Medial flaring of the eyebrow (HP:0010747) | 1.71972232 |
151 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.71743956 |
152 | Generalized tonic-clonic seizures (HP:0002069) | 1.71691947 |
153 | Median cleft lip (HP:0000161) | 1.71621863 |
154 | Progressive cerebellar ataxia (HP:0002073) | 1.71446317 |
155 | CNS demyelination (HP:0007305) | 1.71278296 |
156 | Attenuation of retinal blood vessels (HP:0007843) | 1.70802106 |
157 | Congenital stationary night blindness (HP:0007642) | 1.70502397 |
158 | Furrowed tongue (HP:0000221) | 1.70116360 |
159 | Excessive salivation (HP:0003781) | 1.69049075 |
160 | X-linked dominant inheritance (HP:0001423) | 1.68961778 |
161 | Osteomyelitis (HP:0002754) | 1.68734287 |
162 | Specific learning disability (HP:0001328) | 1.68591781 |
163 | Broad foot (HP:0001769) | 1.68078918 |
164 | Abnormality of the fovea (HP:0000493) | 1.66840309 |
165 | Congenital sensorineural hearing impairment (HP:0008527) | 1.65177650 |
166 | Beaking of vertebral bodies (HP:0004568) | 1.65085988 |
167 | Conjunctival hamartoma (HP:0100780) | 1.64419646 |
168 | Reduced antithrombin III activity (HP:0001976) | 1.63331655 |
169 | Oligomenorrhea (HP:0000876) | 1.62449954 |
170 | Nausea (HP:0002018) | 1.61259030 |
171 | Abnormal glycosylation (HP:0012345) | 1.59056299 |
172 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59056299 |
173 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59056299 |
174 | Abnormal protein glycosylation (HP:0012346) | 1.59056299 |
175 | Birth length less than 3rd percentile (HP:0003561) | 1.58447564 |
176 | Recurrent cutaneous fungal infections (HP:0011370) | 1.57868033 |
177 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.57868033 |
178 | Purpura (HP:0000979) | 1.57693652 |
179 | Nephrogenic diabetes insipidus (HP:0009806) | 1.57580765 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K12 | 3.79091298 |
2 | CASK | 3.33501652 |
3 | WNK3 | 3.07215479 |
4 | MAP4K2 | 3.04464296 |
5 | RIPK4 | 3.00047376 |
6 | TRIM28 | 2.94324332 |
7 | MAP3K4 | 2.67380608 |
8 | PBK | 2.57341257 |
9 | MST4 | 2.52443974 |
10 | PIM2 | 2.46491981 |
11 | BMPR2 | 2.45368500 |
12 | MYLK | 2.14484717 |
13 | NME2 | 2.12537996 |
14 | STK16 | 2.11537711 |
15 | EIF2AK1 | 2.06667582 |
16 | EIF2AK3 | 2.05528219 |
17 | MAP3K14 | 1.99982875 |
18 | PINK1 | 1.96919388 |
19 | PLK2 | 1.93890811 |
20 | MARK1 | 1.93618499 |
21 | BLK | 1.90060876 |
22 | NME1 | 1.89653259 |
23 | ERBB3 | 1.85630633 |
24 | IRAK3 | 1.77444502 |
25 | IRAK4 | 1.76096127 |
26 | MAP2K7 | 1.67366041 |
27 | TXK | 1.64964828 |
28 | TBK1 | 1.64951320 |
29 | ADRBK2 | 1.63525619 |
30 | MAPK13 | 1.60028822 |
31 | EPHA3 | 1.56957162 |
32 | ARAF | 1.53004349 |
33 | PRPF4B | 1.51340203 |
34 | SRPK1 | 1.49043622 |
35 | KIT | 1.48318229 |
36 | GRK7 | 1.46314133 |
37 | CSNK1G2 | 1.46173119 |
38 | STK24 | 1.46137042 |
39 | CSNK1G1 | 1.43803538 |
40 | SIK3 | 1.41015145 |
41 | MUSK | 1.29561336 |
42 | PAK3 | 1.26375266 |
43 | CSNK1G3 | 1.24860518 |
44 | TRPM7 | 1.24125676 |
45 | EPHA4 | 1.23110218 |
46 | DYRK2 | 1.22825302 |
47 | VRK1 | 1.19222472 |
48 | JAK3 | 1.18868798 |
49 | GRK1 | 1.18757381 |
50 | PLK3 | 1.15836170 |
51 | TEC | 1.13689863 |
52 | FGFR2 | 1.13371301 |
53 | TNIK | 1.13059057 |
54 | NEK9 | 1.10319435 |
55 | PNCK | 1.09502514 |
56 | SYK | 1.09271040 |
57 | PLK4 | 1.06074194 |
58 | CCNB1 | 1.05548801 |
59 | INSRR | 1.04463168 |
60 | WEE1 | 1.04139470 |
61 | IKBKB | 1.03801061 |
62 | CDK8 | 1.02214391 |
63 | ZAK | 1.00462278 |
64 | YES1 | 1.00341824 |
65 | DAPK2 | 0.99945848 |
66 | IKBKE | 0.99010641 |
67 | CAMKK2 | 0.97756476 |
68 | OXSR1 | 0.95608699 |
69 | PRKCG | 0.95378319 |
70 | MAP2K4 | 0.92299983 |
71 | DAPK1 | 0.91391224 |
72 | NLK | 0.90559186 |
73 | LIMK1 | 0.89467016 |
74 | CDK19 | 0.89450413 |
75 | TGFBR1 | 0.88619478 |
76 | BRAF | 0.85681539 |
77 | TYK2 | 0.85357529 |
78 | ABL2 | 0.83661016 |
79 | BMPR1B | 0.83552315 |
80 | CSNK1A1L | 0.82314317 |
81 | NTRK3 | 0.82236933 |
82 | TNK2 | 0.79228832 |
83 | PDK2 | 0.78577264 |
84 | LYN | 0.77146248 |
85 | NTRK2 | 0.76470754 |
86 | DYRK3 | 0.75326259 |
87 | EIF2AK2 | 0.75166352 |
88 | MOS | 0.75129303 |
89 | MINK1 | 0.74957673 |
90 | TESK1 | 0.74874796 |
91 | OBSCN | 0.72557373 |
92 | MKNK2 | 0.72451184 |
93 | ZAP70 | 0.70870971 |
94 | TAOK1 | 0.70474868 |
95 | PHKG1 | 0.70405926 |
96 | PHKG2 | 0.70405926 |
97 | BUB1 | 0.70181219 |
98 | FER | 0.65614111 |
99 | CDK3 | 0.64493158 |
100 | TSSK6 | 0.64192369 |
101 | GRK5 | 0.63026940 |
102 | TAOK3 | 0.62947880 |
103 | KSR1 | 0.62747079 |
104 | TAOK2 | 0.62217007 |
105 | STK3 | 0.60713983 |
106 | MAP3K3 | 0.60480594 |
107 | PRKCE | 0.60049951 |
108 | STK39 | 0.59958578 |
109 | BCKDK | 0.58806812 |
110 | PRKCD | 0.58406345 |
111 | FES | 0.58297235 |
112 | PKN1 | 0.57535639 |
113 | AKT3 | 0.56235882 |
114 | BCR | 0.56191375 |
115 | FLT3 | 0.56151550 |
116 | MKNK1 | 0.52519051 |
117 | MAP3K5 | 0.51506005 |
118 | ADRBK1 | 0.51194966 |
119 | PDK3 | 0.50314970 |
120 | PDK4 | 0.50314970 |
121 | LCK | 0.50301318 |
122 | TIE1 | 0.50073027 |
123 | NEK1 | 0.49585678 |
124 | BTK | 0.47915539 |
125 | DYRK1A | 0.47553437 |
126 | PIM1 | 0.47442262 |
127 | BRSK2 | 0.47125739 |
128 | DAPK3 | 0.46944114 |
129 | MAPKAPK3 | 0.44789609 |
130 | CHUK | 0.44576067 |
131 | CSNK1A1 | 0.44360306 |
132 | CAMK2A | 0.44304662 |
133 | NUAK1 | 0.43372167 |
134 | STK38L | 0.42556162 |
135 | RPS6KA4 | 0.41522961 |
136 | PRKG1 | 0.41275133 |
137 | ILK | 0.40885166 |
138 | WNK4 | 0.40319501 |
139 | MAP4K1 | 0.39784043 |
140 | MAP2K6 | 0.39164958 |
141 | RAF1 | 0.38626022 |
142 | UHMK1 | 0.38612670 |
143 | MAP3K11 | 0.38221225 |
144 | PIK3CA | 0.37976871 |
145 | PLK1 | 0.37746260 |
146 | PRKACA | 0.36236816 |
147 | FRK | 0.34601452 |
148 | FGFR1 | 0.33727623 |
149 | CAMK2D | 0.32969652 |
150 | PRKACB | 0.32120509 |
151 | PTK2B | 0.31848327 |
152 | ACVR1B | 0.31624756 |
153 | SGK2 | 0.31270951 |
154 | CSNK1D | 0.30404879 |
155 | MARK3 | 0.29681328 |
156 | RPS6KA5 | 0.29184949 |
157 | CSNK2A1 | 0.28519429 |
158 | PRKG2 | 0.28474730 |
159 | PASK | 0.27026199 |
160 | TLK1 | 0.26255012 |
161 | CDK5 | 0.24883423 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.24082627 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.32730154 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.31312836 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.08991664 |
5 | Protein export_Homo sapiens_hsa03060 | 2.82721549 |
6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.76380128 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.62115593 |
8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.51324839 |
9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.39033581 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31073211 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27859060 |
12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.22675046 |
13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.20364457 |
14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.17607418 |
15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.17142641 |
16 | Phagosome_Homo sapiens_hsa04145 | 2.05675871 |
17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96284291 |
18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95230490 |
19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.91158926 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82480439 |
21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.77640845 |
22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75500127 |
23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75112134 |
24 | Ribosome_Homo sapiens_hsa03010 | 1.72494162 |
25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72083007 |
26 | RNA polymerase_Homo sapiens_hsa03020 | 1.69836641 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.69427608 |
28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64350455 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63735716 |
30 | Allograft rejection_Homo sapiens_hsa05330 | 1.60871323 |
31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54432692 |
32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54418297 |
33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.51365537 |
34 | Asthma_Homo sapiens_hsa05310 | 1.48233810 |
35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.48032189 |
36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.43440309 |
37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43291185 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41239547 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.37084757 |
40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36025245 |
41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.33559481 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.32534313 |
43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22701410 |
44 | Malaria_Homo sapiens_hsa05144 | 1.22367792 |
45 | Lysosome_Homo sapiens_hsa04142 | 1.21576225 |
46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20341663 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13194303 |
48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10273528 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10084800 |
50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08552847 |
51 | Pertussis_Homo sapiens_hsa05133 | 1.05107161 |
52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03571685 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02587999 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02338248 |
55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98546023 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96647324 |
57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95756447 |
58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94987026 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94784435 |
60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94364437 |
61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92611698 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92586770 |
63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92453938 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.91309361 |
65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91127530 |
66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90546500 |
67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90236968 |
68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89371267 |
69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89304985 |
70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88702432 |
71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85940831 |
72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85009030 |
73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84880855 |
74 | Insulin secretion_Homo sapiens_hsa04911 | 0.84343440 |
75 | Measles_Homo sapiens_hsa05162 | 0.83775687 |
76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82514420 |
77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81149938 |
78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80738640 |
79 | Mineral absorption_Homo sapiens_hsa04978 | 0.80584553 |
80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79110564 |
81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77899491 |
82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77542113 |
83 | Base excision repair_Homo sapiens_hsa03410 | 0.77399939 |
84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76950973 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74239930 |
86 | Shigellosis_Homo sapiens_hsa05131 | 0.73586174 |
87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73412663 |
88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72220726 |
89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71031212 |
90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71019216 |
91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70850151 |
92 | Influenza A_Homo sapiens_hsa05164 | 0.69071766 |
93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67388263 |
94 | Homologous recombination_Homo sapiens_hsa03440 | 0.67217264 |
95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67054864 |
96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66763457 |
97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66463277 |
98 | Mismatch repair_Homo sapiens_hsa03430 | 0.65971578 |
99 | Apoptosis_Homo sapiens_hsa04210 | 0.65314309 |
100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64657692 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63344307 |
102 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62279525 |
103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60735732 |
104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60520280 |
105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60002321 |
106 | Purine metabolism_Homo sapiens_hsa00230 | 0.59186282 |
107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58500112 |
108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57819229 |
109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57391511 |
110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57292005 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57184273 |
112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56951393 |
113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55980722 |
114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55958084 |
115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54307104 |
116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54041603 |
117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53282922 |
118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53007420 |
119 | Salivary secretion_Homo sapiens_hsa04970 | 0.52582535 |
120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50975529 |
121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50953521 |
122 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50531984 |
123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49508320 |
124 | Long-term depression_Homo sapiens_hsa04730 | 0.48794636 |
125 | RNA degradation_Homo sapiens_hsa03018 | 0.47441439 |
126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43407297 |
127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42793048 |
128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42438643 |
129 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42193551 |
130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41838233 |
131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41157614 |
132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41090534 |
133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40112861 |
134 | DNA replication_Homo sapiens_hsa03030 | 0.40023699 |
135 | Taste transduction_Homo sapiens_hsa04742 | 0.38171796 |
136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38048880 |
137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37039180 |
138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36297338 |
139 | RNA transport_Homo sapiens_hsa03013 | 0.35771571 |
140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35117263 |
141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35117262 |
142 | Hepatitis B_Homo sapiens_hsa05161 | 0.33367219 |
143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32514085 |
144 | Morphine addiction_Homo sapiens_hsa05032 | 0.32383609 |
145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28760807 |
146 | ABC transporters_Homo sapiens_hsa02010 | 0.28519808 |
147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27537218 |
148 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26888768 |
149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25029427 |
150 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24524869 |
151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24348624 |
152 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.24249774 |
153 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24073644 |
154 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21473656 |
155 | Phototransduction_Homo sapiens_hsa04744 | 0.19692294 |
156 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.19534582 |
157 | Spliceosome_Homo sapiens_hsa03040 | 0.19074895 |
158 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18596167 |
159 | Platelet activation_Homo sapiens_hsa04611 | 0.17254427 |
160 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17211078 |
161 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17207142 |